Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Newswire.ca - Thu May 16, 11:14AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities Commission (the "OSC") has...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update Newswire.ca - Thu May 2, 8:01AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Newswire.ca - Wed May 1, 9:05AM CDT

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
MRNA : 132.90 (+0.17%)
BOLD : 9.67 (-2.91%)
IBRX : 7.65 (-1.29%)
MGNX : 4.36 (-14.75%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses BayStreet.ca - Wed May 1, 8:54AM CDT

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 22.52 (+1.08%)
BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
MRNA : 132.90 (+0.17%)
BOLD : 9.67 (-2.91%)
IBRX : 7.65 (-1.29%)
MGNX : 4.36 (-14.75%)
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Newswire.ca - Tue Apr 30, 7:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has appointed Christopher Cherry as...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
Navigating the Surge in Aquaculture: Opportunities & Challenges BayStreet.ca - Wed Apr 24, 8:26AM CDT

USA News Group – The way we get our food is in need of a dramatic overhaul, with domestic food inflation remaining high across the globe. However, one aspect of the world’s food supply that’s set...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
MRK : 131.19 (+0.24%)
ZTS : 174.06 (+0.20%)
CTVA : 56.45 (+0.80%)
BG : 103.09 (-0.44%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update Newswire.ca - Thu Apr 18, 3:30PM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY Newswire.ca - Wed Apr 10, 7:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac") jointly announce that SpayVac...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update Newswire.ca - Thu Apr 4, 7:05PM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE Newswire.ca - Wed Apr 3, 7:00AM CDT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance from...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0620 (+3.33%)

Barchart Exclusives

NVDA Earnings, Fed Speakers and Other Key Things to Watch This Week Barchart - Sun May 19, 2:00PM CDT
There was some wild volatility last week as PPI came in hotter than expected and CPI came in just under expectations on the monthly basis. This small decrease in the inflation rate was enough for Fed heads to start talking about rate cuts again the next day. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot